PatientID: 5
KindredID: 5
Case: M, Age Unknown, Ethnicity Unknown
DiseaseAssertion: VHL
FamilyInfo: N/A
CasePresentingHPOs: HP:0000107; HP:0005584; HP:0010797; HP:0001737; HP:0009711 (Renal cyst, Renal cell carcinoma, Hemangioblastoma, Pancreatic cysts, Retinal capillary hemangioma)
CaseHPOFreeText: Bilateral RCC add renal cysts, CNS hemangioblastoma, positive for pancreatic cysts, retinal hemangioblastoma.
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CasePreviousTesting: N/A
PreviouslyPublished: N/A
SupplementalData: Table 1
Variant: p.W117C (c.351G>T)
LegacyVariant: c.564G>T (W117C)
CaseProblemVariantFreeText: N/A
ClinVarID: 167827, https://www.ncbi.nlm.nih.gov/clinvar/variation/167827/
CAID: N/A
gnomAD: N/A
VariantEvidence: Variant is declared as “c.564G>T (W117C)” by the authors, this was treated as a legacy variant and mapped to c.351G>T, W117C. This study found coexpression of Epo and EpoR in 11 RCCs and in 10 benign renal cysts in a spectrum of VHL renal disease suggesting that Epo/EpoR coexpression is present in both benign and malignant stages of renal neoplasia. Six benign cysts stained for Epo but not EpoR. The researchers detected loss of heterozygosity of a wild-type VHL allele in different RCCs with microsatellite markers, D3S1110 and D3S2452, flanking the VHL gene
MutationType: missense_variant;transversion
CivicName: W117C (c.351G>T)
MultipleGeneVariants: N/A